Golden State Equity Partners’s Boston Scientific BSX Stock Holding History

Golden State Equity Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.96K	Sell	46 -10,736	-100%	-$583K	0.01%	334
2026 Q1	$677K	Sell	10,782 -1,498	-12%	-$120K	0.05%	371
2025 Q4	$1.17M	Buy	12,280 +2,475	+25%	+$243K	0.19%	121
2025 Q3	$957K	Buy	9,805 +18	+0.2%	+$1.86K	0.16%	156
2025 Q2	$1.05M	Sell	9,787 -2	-0%	-$202	0.19%	130
2025 Q1	$988K	Sell	9,789 -1,079	-10%	-$109K	0.2%	135
2024 Q4	$971K	Buy	10,868 +9,831	+948%	+$865K	0.19%	133
2024 Q3	$86.9K	Sell	1,037 -9,426	-90%	-$743K	0.05%	297
2024 Q2	$806K	Buy	+10,463	New	+$766K	0.17%	141
2021 Q2	–	Sell	-8,608	Closed	-$333K	–	257
2021 Q1	$333K	Buy	8,608 +313	+4%	+$11.8K	0.19%	118
2020 Q4	$298K	Buy	+8,295	New	+$299K	0.21%	121

Other funds holding BSX

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Golden State Equity Partners's BSX Position: Q2 2026 in Review

Golden State Equity Partners reduced its Boston Scientific (BSX) stake by 100% in Q2 2026, selling an estimated $583K and leaving 46 shares worth $1.96K. The position accounts for 0.01% of the portfolio, ranked #334.

Golden State Equity Partners first reported a position in BSX in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.17M in Q4 2025. 641 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Golden State Equity Partners held 46 shares of Boston Scientific worth $1.96K as of Q2 2026.
Golden State Equity Partners sold 10,736 Boston Scientific shares in Q2 2026, an estimated $583K.
Boston Scientific made up 0.01% of Golden State Equity Partners's portfolio in Q2 2026, its #334 holding.
Golden State Equity Partners first reported a position in Boston Scientific in Q4 2020 and has held it in 11 quarters since.
Golden State Equity Partners's Boston Scientific position peaked at $1.17M in Q4 2025.
641 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.